Classes
Publications
- Cytochrome b(5) shifts oxidation of the anticancer drug ellipticine by cytochromes P450 1A1 and 1A2 from its detoxication to activation, thereby modulating its pharmacological efficacy2011 | Faculty of Science
- Isolation and partial characterization of the adduct formed by 13-hydroxyellipticine with deoxyguanosine in DNA2008 | Faculty of Science
- Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: Studies with the hepatic NADPH: Cytochrome P450 reductase null mouse +12008 | Faculty of Science
- The anticancer drug ellipticine is a potent inducer of rat cytochromes P450 1A1 and 1A2, thereby modulating its own metabolism2007 | Faculty of Science
- The anticancer drug ellipticine is an inducer of rat NAD(P)H : Quinone oxidoreductase2007 | Faculty of Science
- Studies with the hepatic NADPH:cytochrome P450 reductase null mouse reveal the role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine2007 | Faculty of Science
- Oxidation of ellipticine by human and rat cytochromes P450 correlates with its binding to DNA2007 | Faculty of Science
- Kinetics of ellipticine oxidation by cytochromes P450 1A1 and 1A2 reconstituted with NADPH:cytochrome P450 reductase2007 | Faculty of Science
- Comparison of the cytotoxicity of and DNA adduct formation by the anticancer drug ellipticine in human breast adenocarcinoma, leukemia and neuroblastoma cells2007 | Faculty of Science
- The effect of pH on peroxidase-mediated oxidation of and DNA adduct formation by ellipticine2006 | Faculty of Science
Loading network view...